Thyroid hormone receptors and stimulation of angiotensinogen production in HepG2 cells

Summary Binding characteristics and effects of 3,5,-3′-triiodo-l-thyronine (T₃) on angiotensinogen production in HepG₂ were studied in serum-free medium. Binding was performed on intact cells and on partially purified isolated nuclei using [¹²⁵I]T₃. Scatchard plots revealed one class of high affinity binding sites with a K_d of approximately 80 pmol/liter. Calculation of maximum binding showed that HepG₂ possess approximately 1000 binding sites per cell. Unlabeled T₃ and T₄ competed for binding sites on intact HepG₂ with 50% inhibition of [¹²⁵I]T₃ binding at approximately 3.0 and 38.0 pmol/liter, respectively. The HepG₂ showed a dose-dependent increase in angiotensinogen production in serum-free medium which was maximal at 10⁻⁵ mol/liter (two-fold increase/10⁶ cells/24 h) and had an EC₅₀ of approximately 5.0×10⁻⁸ mol/liter. T₃ also produced after 24 h a dose-dependent increase in DNA highly correlated with T₃ applied (r=0.88,P<0.01). In conclusion, this study shows that HepG₂ possess specific high affinity binding sites for T₃ and that T₃ stimulates angiotensinogen production and DNA synthesis in these cells. Dr. Darby is supported by INSERM (France)/NH and MRC (Australia) exchange fellowship.